NCT06309277 A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD Status COMPLETED Phase PHASE2
NCT06306209 Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach Status RECRUITING Phase N/A
NCT06299787 Cognitive Dysfunction in the Addictions Study - Project 4 (P4) Status RECRUITING Phase NA
NCT06293781 Application of the Web-based Acceptance and Commitment Therapy for Depression Status RECRUITING Phase NA
NCT06271954 The Relationship Between Emotion Regulation and Psychiatric Disorder in Youth Status RECRUITING Phase N/A
NCT06267846 A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT06255561 pBFS Guided rTMS Over Different Targets for Treatment-Resistant Depression Status UNKNOWN Phase NA
NCT06254612 A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT06247839 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder Status RECRUITING Phase PHASE3
NCT06236880 A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD Status RECRUITING Phase PHASE2
NCT06235905 Open-Label of SPN-820 in Adults With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT06234176 Impact of Psychomotor Therapy on the Quality of Life in Depression Status RECRUITING Phase NA
NCT06232291 Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression Status COMPLETED Phase N/A